Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2026-01-05 @ 12:52 PM
Study NCT ID:
NCT03732560
Status:
COMPLETED
Last Update Posted:
2022-12-08
First Post:
2018-11-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Comparison of Nivolumab-based Treatments in a Real-world PD-L1 Positive Metastatic Melanoma Population in the US
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-31
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-03-25
Completion Date Type:
ACTUAL
First Submit Date:
2018-11-05
First Submit QC Date:
None
Study First Post Date:
2018-11-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-06
Last Update Post Date:
2022-12-08
Last Update Post Date Type:
ACTUAL